Inside February 2014 Edition
| President's Message | SITC in Action |
In Memoriam |
Society Updates |
Dear Colleagues,
With a Society-sponsored meeting sparking international collaboration as well as a major development for our official journal, it was a good month to be a SITC member!
Journal for ImmunoTherapy of Cancer Now Indexed in PubMed Central
PubMed Central indexed our official journal in January. Handling over 1,300 hits per second, PubMed Central is one of the leading digital databases for full-text scientific literature. Inclusion makes it easier for scientists, clinicians, patients, educators, and students to read and cite your JITC articles.
With this expanded access as well as waived processing charges for members (a $2,400 USD savings), now is the perfect time to submit your manuscript.
Updates on Immunotherapy of Cancer and Immunoscore Recap
On January 21-23, SITC collaborated with the Sidra Medical and Research Center to host the Updates on Immunotherapy of Cancer and Immunoscore symposium in Doha, Qatar. Visionaries in the field of cancer immunotherapy discussed ways to improve cancer patient outcomes through immunotherapy and attracted attendees from around the world.
To read more about the symposium as covered in The Gulf Times, click here.
This is all great news for the Society, but it is also great news for you. The year is just underway, so keep an eye out for new programs, initiatives, and educational opportunities.
.jpg){kind=small}
Francesco M. Marincola, MD, FACS
SITC President
SITC Raises Cancer Immunotherapy Awareness on World Cancer Day
On February 4, SITC observed World Cancer Day! The global event aims to recognize all types of cancer and all forms of cancer treatment, so SITC made sure immunotherapy didn't go unnoticed.
The SITC team took to social media in support of the event and created an immunotherapy awareness badge (see right) that was downloaded and retweeted dozens of times by immunotherapy supporters all over the globe. Thank you to everyone who participated in the event by sharing, forwarding and retweeting our immunotherapy content.
Still want to spread cancer immunotherapy awareness? To download badge, right click the badge and "Save Image As..."
To follow SITC on Twitter, click here.
New $100,000 SITC Fellowship - Application Begins in 2 Weeks
Do you know a young investigator in search of funding for clinical research in cancer immunotherapy?
On February 24, SITC will begin accepting applications for the first-ever SITC-EMD Serono Cancer Immunotherapy Clinical Fellowship, a one-year, $100,000 award that covers support for salary, equipment, supplies, and fringe benefits.
Society membership is required to apply, so make sure you are current in your dues! For membership information, please click here.
To learn more about the SITC-EMD Serono fellowship, click here to read our press release.
Remembering Donald L. Morton, MD
Considered one of the world's foremost authorities in the research and treatment of melanoma, Dr. Donald L. Morton passed away on January 10, 2014, leaving behind a lasting legacy as one of the most famous cancer surgeons in the world.
As the Chief of the Melanoma Program and Co-Director of the Surgical Oncology Fellowship Program at John Wayne Cancer Institute (JWCI) in Santa Monica, CA and an active member of the SITC for more than 13 years, Dr. Morton contributed significantly to the Society through his volunteer efforts at SITC meetings and educational programs.
SITC is deeply saddened by the loss of Dr. Morton and our sincere condolences go to his family and friends. For more information and to read SITC's article in full, click here.
New Jobs from SITC's Job Board
Aduro Biotech, Inc.
Immune Monitoring & Biomarker Development, Senior Scientist
MacroGenics, Inc.
Clinical Research Physician
Moffitt Cancer Center
Director, Cell Therapies Facility
Thoracic Medical Oncologist
To submit a job positing or view our complete list of job postings, click here.
Events Calendar
SITC Events
- Advances in Cancer Immunotherapy (ACI)
Held Prior to the ASCO Annual Meeting
May 30, 2014 – Chicago, IL
Registration opens in March!
- Save the Date for SITC 2014!
SITC Collaborative Events
- SITC Cancer Immunotherapy Session at the ITOC-1 Immunotherapy of Cancer Conference
March 12-14, 2014 – Munich, Germany
- Therapeutic Cancer Vaccines: Dinosaurs or Key Components?
SITC/CIMM Town Hall at the AACR Annual Meeting
April 8, 2014 – San Diego, CA
- Cancer Immunology and Immunotherapy: From Basic Science to Clinical Application
SITC Guest Society Session at the AAI Annual Meeting
May 5, 2014 - Pittsburgh, PA
Recently Published Articles in JITC
 |
Recombinant interleukin-21 plus sorafenib for metastatic renal cell carcinoma: a phase 1/2 study |
Shailender Bhatia, Brendan Curti, Marc S Ernstoff, Michael Gordon, Elisabeth I Heath, Wilson H Miller, Igor Puzanov, David I Quinn, Thomas W Flaig, Peter VanVeldhuizen, Kelly Byrnes-Blake, Jeremy A Freeman, Rachel Bittner, Naomi Hunder, Sonia Souza, John A Thompson
Journal for ImmunoTherapy of Cancer 2014, 2:2 (27 January 2014)
|
Immunoglobulin-like transcript 2 (ILT2) is a biomarker of therapeutic response to oncolytic immunotherapy with vaccinia viruses |
Andrew Zloza, Dae Won Kim, Seunghee Kim-Schulze, Michael C Jagoda, Vladia Monsurro, Francesco M Marincola, Howard L Kaufman
Journal for ImmunoTherapy of Cancer 2014, 2:1 (27 January 2014)
Stay tuned! JITC's next edition will be published on Tuesday, February 18, 2014.
